Stay updated on Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.

Latest updates to the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page shows a minor revision update, adding Revision: v3.3.2 and removing Revision: v3.3.1 in the change log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 removed; This appears to be a cosmetic site update that does not affect the study content or user-facing functions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page no longer displays the government funding status notice, an operational banner; this change does not alter trial details, eligibility criteria, outcomes, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check32 days agoChange DetectedThe Study Details page now displays 'Results Submitted' instead of 'No Results Posted.' This updates the results status shown on the page, signaling that trial results have been submitted and are available in the results database.SummaryDifference0.5%

- Check61 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

- Check68 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.